Here are four takeaways:
1. The Drug Enforcement Administration began investigating the health system after a nurse and an anesthesiology resident overdosed on stolen opioids in 2013. The nurse’s overdose was fatal.
2. The health system reportedly failed to secure DEA registrations for 15 offsite ambulatory care locations, which gave patients narcotics from the main hospital’s pharmacy. This was one of several Controlled Substances Act violations, U.S. Attorney Matthew Schneider said.
3. The system also allegedly had insufficient protections against opioid theft and diversion due to “significant” record-keeping violations.
4. This is the nation’s largest settlement involving alleged diversion of controlled substances.
More articles on supply chain:
Alcon recalls micro-invasive glaucoma surgical implant — 5 insights
ASC supply chain tip of the day: Monitor key performance metrics
OR Supply Chain- Time for Collaboration
